Table 5.
Unit | Odds ratio | 95% confidence interval | p-value | |
---|---|---|---|---|
B cells |
|
|
|
|
CD19+ |
cells/mm3 |
0.65 |
[0.36; 1.15] |
0.1373 |
CD27-IgD+ |
% CD19+ |
1.49 |
[0.89; 2.48] |
0.1310 |
CD27-IgD- |
% CD19+ |
0.54 |
[0.24; 1.23] |
0.1401 |
CD27 + IgD+ |
% CD19+ |
0.62 |
[0.34; 1.12] |
0.1124 |
CD27 + IgD- |
% CD19+ |
0.93 |
[0.29; 0.86] |
0.0119 |
T cells |
|
|
|
|
CD3+ |
cells/mm3 |
0.68 |
[0.40; 1.17] |
0,1646 |
CD4+ |
cells/mm3 |
0.45 |
[0.26; 0.78 ] |
0,0046 |
CD8+ |
cells/mm3 |
1.04 |
[0.66; 1.62 ] |
0.8818 |
CD4+/CD8+ ratio |
|
0.99 |
[0.63; 1.56 ] |
0.9649 |
CD8+ T cells
|
|
|
|
|
CD45RA + CCR7+ |
% CD8+ |
0.69 |
[0.43; 1.13] |
0.1385 |
CD45RA-CCR7+ |
% CD8+ |
0.75 |
[0.46; 1.25] |
0.2710 |
CD45RA-CCR7- |
% CD8+ |
1.38 |
[0.86; 2.20] |
0.1800 |
CD45RA + CCR7- |
% CD8+ |
0.77 |
[0.48; 1.23] |
0.2666 |
CD8 + CD57+ |
% CD8+ |
1.30 |
[0.83; 2.06] |
0.2567 |
Activated T cells
|
|
|
|
|
CD3 + HLA-DR+ |
% CD3+ |
2.99 |
[1.56; 5.73] |
0.0010 |
CD4 + HLA-DR+ |
% CD4+ |
2.70 |
[1.40; 5.23] |
0.0032 |
CD8 + HLA-DR+ |
% CD8+ |
2.75 |
[1.54; 4.90] |
0.0006 |
Regulatory T cells |
cells/mm3 |
0.41 |
[0.22; 0.78] |
0.0065 |
Natural Killer cells |
cells/mm3 |
0.75 |
[0.46; 1.21] |
0.2369 |
Dendritic cells |
|
|
|
|
Myeloid |
/ml |
0.65 |
[0.36; 1.17] |
0.1532 |
Plasmacytoid |
/ml |
0.37 |
[0.18; 0.73] |
0.0046 |
Gammadelta cells |
cells/mm3 |
1.30 |
[0.79; 2.13] |
0.3028 |
Gammadelta 2 cells | % GD | 0.52 | [0.32; 0.85] | 0.0087 |
Univariable logistic regression analysis (Odds ratio per 1 standard deviation).
ALTADIH Cohort, 2007-2010.